1. Home
  2. BRLT vs VTGN Comparison

BRLT vs VTGN Comparison

Compare BRLT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brilliant Earth Group Inc.

BRLT

Brilliant Earth Group Inc.

HOLD

Current Price

$1.15

Market Cap

22.5M

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.64

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRLT
VTGN
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
24.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BRLT
VTGN
Price
$1.15
$0.64
Analyst Decision
Hold
Hold
Analyst Count
4
3
Target Price
$1.70
$0.90
AVG Volume (30 Days)
62.0K
681.1K
Earning Date
05-06-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$437,483,000.00
N/A
Revenue This Year
$6.72
$124.49
Revenue Next Year
$4.95
$353.99
P/E Ratio
N/A
N/A
Revenue Growth
3.63
N/A
52 Week Low
$1.12
$0.43
52 Week High
$3.10
$5.14

Technical Indicators

Market Signals
Indicator
BRLT
VTGN
Relative Strength Index (RSI) 37.10 53.83
Support Level N/A $0.63
Resistance Level $1.64 $0.64
Average True Range (ATR) 0.10 0.05
MACD -0.03 0.00
Stochastic Oscillator 18.75 56.09

Price Performance

Historical Comparison
BRLT
VTGN

About BRLT Brilliant Earth Group Inc.

Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Share on Social Networks: